Disclosures for "Impact of Disease-modifying Therapies on Cognitive Function and Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Systematic Review"
-
Miss Leite has nothing to disclose.
-
Miss Morgado has nothing to disclose.
-
Mrs. Cortines has nothing to disclose.
-
Mr. Candido has nothing to disclose.
-
Mrs. Moreira has nothing to disclose.
-
Dr. Moura has nothing to disclose.
-
Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Rezende has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Aztrazeneca. Dr. Rezende has received research support from ECTRIMS.
-
Dr. Carvalho has nothing to disclose.
-
Prof. da Costa has nothing to disclose.
-
Author has nothing to disclose